Psychedelics Today

PT350 – Jim Gilligan – Psilocybin and Accessing the “Off” Switch For Nociplastic Pain

08.26.2022 - By Psychedelics TodayPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain.  www.psychedelicstoday.com

More episodes from Psychedelics Today